Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PRECISE, a two arm, double blind randomised controlled trial of pregabalin in addition to usual care compared to placebo with usual care for reducing leg pain in patients with sciatica.

Trial Profile

PRECISE, a two arm, double blind randomised controlled trial of pregabalin in addition to usual care compared to placebo with usual care for reducing leg pain in patients with sciatica.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Jul 2017

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Pain; Sciatica
  • Focus Therapeutic Use
  • Acronyms PRECISE

Most Recent Events

  • 18 Jul 2017 Results published in the Annals of Internal Medicine
  • 31 Mar 2017 Status changed from active, no longer recruiting to completed.
  • 23 Mar 2017 Primary endpoint (Average leg pain intensity over the last 24 hours measured by the numeral pain rating scale) has not been met, according to the results published in the New England Journal of Medicine

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top